Literature DB >> 18997660

Update on the use of mTOR inhibitors in renal cell carcinoma.

Brian I Rini.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18997660

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN: 1543-0790


× No keyword cloud information.
  1 in total

Review 1.  Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma.

Authors:  Sumanta Kumar Pal; Robert A Figlin
Journal:  Target Oncol       Date:  2011-04-12       Impact factor: 4.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.